ArticlePCN reports : psychiatry and clinical neurosciences2025
A retrospective risk factor analysis in psychiatric inpatients with COVID-19 from 2020 to 2023 at a neuropsychiatric hospital in Tokyo.
Article in PCN reports : psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A retrospective risk factor analysis in psychiatric inpatients with COVID-19 from 2020 to 2023 at a neuropsychiatric hospital in Tokyo.PCN reports : psychiatry and clinical neurosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To identify the factors associated with the severity and prognosis of coronavirus disease 2019 (COVID-19) in patients with psychiatric or neurological disorders. Methods: We retrospectively analyzed the clinical characteristics and treatment outcomes of 349 patients with those disorders who were admitted for COVID-19 at the National Center of Neurology and Psychiatry between June 2020 and March 2023. The study period was divided into three phases: June-December 2020, January-December 2021, and January 2022 to March 2023 according to the differences in types of COVID-19 variants and our clinical care systems. Differences across phases were analyzed using the Kruskal-Wallis test. Logistic regression was performed to identify factors associated with moderate II or higher COVID-19 and all-cause mortality. Results: A total of 36 (10.3%), 107 (30.7%), and 206 (59.0%) patients were admitted in the first, second, and third phases, respectively. The average age of the patients was 66.4 ± 17.9 years, and 47% of them were female. Aspiration pneumonia complicated by COVID-19 was strongly associated with moderate II or higher (odds ratio [OR] = 10.871, Conclusion: These findings suggest that patients with psychiatric disorders, particularly elderly individuals or those with aspiration pneumonia, are associated with moderate II or higher COVID-19. Further prospective observational studies are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.